Genomics of Nephrotic Syndrome
Contact
Description
- The risk of developing nephrotic syndrome
- The response to treatment of nephrotic syndrome and
- The risk of recurrence of nephrotic syndrome following kidney transplantation.
To be eligible, participants must have:
- Clinical diagnosis of nephrotic syndrome
- Biopsy proven diagnosis of FSGS or MCD and,
- History of living or deceased donor kidney transplantation
Eligibility and criteria
IRB Number:
21-019548
Clinical trial phase:
N/A
Official title:
What to expect
Related specialties
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.